Overview

Efficacy and Safety of NYX-2925 in Subjects With Fibromyalgia

Status:
Recruiting
Trial end date:
2022-06-01
Target enrollment:
Participant gender:
Summary
To evaluate the efficacy of NYX-2925 versus placebo for the treatment of fibromyalgia.
Phase:
Phase 2
Details
Lead Sponsor:
Aptinyx
Collaborators:
Syneos Health
Worldwide Clinical Trials